Scor SE [SCR] vs Axa S.A [CS] Detailed Stock Comparison

Scor SE

Axa S.A
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Scor SE wins in 10 metrics, Axa S.A wins in 7 metrics, with 0 ties. Scor SE appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Scor SE | Axa S.A | Better |
---|---|---|---|
P/E Ratio (TTM) | 10.13 | 12.27 | Scor SE |
Price-to-Book Ratio | 1.31 | 1.89 | Scor SE |
Debt-to-Equity Ratio | 56.12 | 116.60 | Scor SE |
PEG Ratio | 0.00 | N/A | N/A |
EV/EBITDA | 7.40 | N/A | N/A |
Profit Margin (TTM) | 3.35% | 8.36% | Axa S.A |
Operating Margin (TTM) | 7.22% | 11.48% | Axa S.A |
EBITDA Margin (TTM) | 7.22% | 11.48% | Axa S.A |
Return on Equity | 8.40% | 12.97% | Axa S.A |
Return on Assets (TTM) | 1.62% | 1.00% | Scor SE |
Free Cash Flow (TTM) | $875.00M | $11.99B | Axa S.A |
Dividend Yield | 6.36% | 5.15% | Scor SE |
1-Year Return | 46.09% | 12.40% | Scor SE |
Price-to-Sales Ratio (TTM) | 0.33 | 0.93 | Scor SE |
Enterprise Value | $7.45B | $91.91B | Axa S.A |
EV/Revenue Ratio | 0.46 | 0.99 | Scor SE |
Revenue per Share (TTM) | $90 | $43 | Scor SE |
Earnings per Share (Diluted) | $2.98 | $3.29 | Axa S.A |
Beta (Stock Volatility) | 0.91 | 1.07 | Scor SE |
Scor SE vs Axa S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Scor SE | 0.40% | 1.88% | 9.70% | 7.52% | 38.99% | 25.31% |
Axa S.A | -2.33% | -2.76% | -0.80% | -5.03% | 12.08% | 14.58% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Scor SE | 46.09% | 113.38% | 26.67% | -5.40% | 61.17% | 61.17% |
Axa S.A | 12.40% | 66.27% | 160.33% | 72.91% | 195.65% | 78.62% |
News Based Sentiment: Scor SE vs Axa S.A
Scor SE
News based Sentiment: MIXED
Scor is demonstrating positive strategic moves with its business diversification and digital transformation, reflected in improved valuation and recent earnings beats. However, the significant increase in short interest and projected slight loss for the year introduce uncertainty, creating a mixed investment narrative.
Axa S.A
News based Sentiment: POSITIVE
October was a strong month for AXA, marked by strategic investments in AI and cloud technology, positive analyst ratings, and robust financial performance. The company is capitalizing on growth opportunities in renewable energy insurance and demonstrating a commitment to sustainability, all contributing to a positive outlook for investors.
Performance & Financial Health Analysis: Scor SE vs Axa S.A
Metric | SCR | CS |
---|---|---|
Market Information | ||
Market Cap | €5.40B | €86.15B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 359,003 | 2,494,808 |
90 Day Avg. Volume | 392,842 | 3,790,744 |
Last Close | €30.30 | €39.44 |
52 Week Range | €18.75 - €30.64 | €31.73 - €43.61 |
% from 52W High | -1.11% | -9.56% |
All-Time High | €43.79 (Nov 05, 2018) | €43.61 (Aug 15, 2025) |
% from All-Time High | -30.81% | -9.56% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.04% | 0.04% |
Quarterly Earnings Growth | N/A | -0.02% |
Financial Health | ||
Profit Margin (TTM) | 0.03% | 0.08% |
Operating Margin (TTM) | 0.07% | 0.11% |
Return on Equity (TTM) | 0.08% | 0.13% |
Debt to Equity (MRQ) | 56.12 | 116.60 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | €23.09 | €21.32 |
Cash per Share (MRQ) | €19.93 | €33.44 |
Operating Cash Flow (TTM) | €1.16B | €20.97B |
Levered Free Cash Flow (TTM) | €530.75M | €8.05B |
Dividends | ||
Last 12-Month Dividend Yield | 6.36% | 5.15% |
Last 12-Month Dividend | €1.80 | €2.15 |
Valuation & Enterprise Metrics Analysis: Scor SE vs Axa S.A
Metric | SCR | CS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 10.13 | 12.27 |
Forward P/E | 7.31 | 10.57 |
PEG Ratio | 0.00 | N/A |
Price to Sales (TTM) | 0.33 | 0.93 |
Price to Book (MRQ) | 1.31 | 1.89 |
Market Capitalization | ||
Market Capitalization | €5.40B | €86.15B |
Enterprise Value | €7.45B | €91.91B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.46 | 0.99 |
Enterprise to EBITDA | 7.40 | N/A |
Risk & Other Metrics | ||
Beta | 0.91 | 1.07 |
Book Value per Share (MRQ) | €23.09 | €21.32 |
Financial Statements Comparison: Scor SE vs Axa S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SCR | CS |
---|---|---|
Revenue/Sales | N/A | N/A |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | N/A | N/A |
Income Tax | N/A | N/A |
Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SCR | CS |
---|---|---|
Cash & Equivalents | €2.11B | €22.46B |
Total Current Assets | N/A | N/A |
Total Current Liabilities | N/A | N/A |
Long-Term Debt | €3.52B | €76.32B |
Total Shareholders Equity | €4.52B | €47.90B |
Retained Earnings | €4.00M | €35.58B |
Property, Plant & Equipment | €960.00M | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SCR | CS |
---|---|---|
Operating Cash Flow | €-109.46M | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | €216.94M | N/A |
Debt Repayment | €-103.17M | N/A |
Common Stock Repurchase | €-825,200 | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SCR | CS |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 359,003 | 2,494,808 |
Average Daily Volume (90 Day) | 392,842 | 3,790,744 |
Shares Outstanding | 179.37M | 2.18B |
Float Shares | 163.96M | 1.57B |
% Held by Insiders | 0.03% | 0.20% |
% Held by Institutions | 0.49% | 0.41% |
Dividend Analysis & Yield Comparison: Scor SE vs Axa S.A
Metric | SCR | CS |
---|---|---|
Last 12-Month Dividend | €1.80 | €2.15 |
Last 12-Month Dividend Yield | 6.36% | 5.15% |
3-Year Avg Annual Dividend | €1.67 | €1.94 |
3-Year Avg Dividend Yield | 6.27% | 5.92% |
3-Year Total Dividends | €5.00 | €5.83 |
Ex-Dividend Date | May 02, 2025 | May 05, 2025 |